Predictmedix launches clinical trial AI platform

Executive Summary

• Predictmedix AI Inc. launched a next‑generation artificial‑intelligence platform for clinical‑trial planning, modeling and adaptation.
• The solution integrates patient, protocol, site, historical outcome and cost data to run adaptive “what‑if” simulations in real time.
• The company will begin private demonstrations and seek paid pilot programs with pharmaceutical sponsors and CROs.

Key Details

• Platform built on patented technology and the SmartHealth AI station data set (≈ 500,000 scans, ~95 % accuracy for vital‑sign detection).
• Adaptive simulation engine – runs scenario analyses and refreshes projections as enrollment and site performance data are received.
• Patient‑site optimization – AI‑driven matching to improve recruitment and reduce dropouts.
• Cost & ROI modeling – proprietary algorithms estimate budget impact alongside predicted clinical outcomes.
• Interactive dashboards – executive and audit views with dynamic heat maps and Sankey plots for risk, cost, and patient‑flow visualization.
• Compliance‑integrated AI – tracks data inputs and simulations to support audit and regulatory processes.
• Market context: Global clinical‑trial market projected to exceed $70 billion by 2027; platform aims to reduce trial failures, improve recruitment, and manage costs.
• Company plans private demos and exploration of paid pilot programs with pharma sponsors and CROs.

Notable Quotes

“Clinical development urgently needs smarter tools,” said Dr. Rahul Kushwah, Chief Operating Officer of Predictmedix. “Our platform is designed to highlight potential clinical trial challenges early, enabling sponsors to make informed adjustments that can help save time and resources and, ultimately, support faster delivery of new therapies.”